135 related articles for article (PubMed ID: 37691350)
21. Contribution of crosstalk of mesothelial and tumoral epithelial cells in pleural metastasis of lung cancer.
Li PH; Zhang X; Yan H; Xia X; Deng Y; Miao Q; Luo Y; Liu G; Luo H; Zhang Y; Xu H; Jiang L; Li ZH; Shu Y
Transl Lung Cancer Res; 2024 May; 13(5):965-985. PubMed ID: 38854934
[TBL] [Abstract][Full Text] [Related]
22. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
[TBL] [Abstract][Full Text] [Related]
23. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
Song Z; Wang W; Li M; Liu J; Zhang Y
Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
[TBL] [Abstract][Full Text] [Related]
24. Cytokine/Chemokine/Growth Factor Levels in Malignant Pleural Effusion of Non-small Cell Lung Cancer.
Hayama N; Hattori S; Takahashi G; Takahashi F; Takeuchi T; Tanaka J; Horio Y; Takiguchi H; Tomomatsu K; Kitahara A; Takihara T; Niimi K; Oguma T; Asano K
Tokai J Exp Clin Med; 2020 Dec; 45(4):224-229. PubMed ID: 33300594
[TBL] [Abstract][Full Text] [Related]
25. Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
Lee J; Park JE; Choi SH; Seo H; Lee SY; Lim JK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2022 Jan; 37(1):137-145. PubMed ID: 33045810
[TBL] [Abstract][Full Text] [Related]
26. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and survival impact of polymorphonuclear leucocyte-predominant malignant pleural effusions secondary to lung cancer.
Lee J; Lee YH; Seo H; Do YW; Lee DH; Lee SY; Lim JK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Clin Respir J; 2020 Aug; 14(8):772-779. PubMed ID: 32294312
[TBL] [Abstract][Full Text] [Related]
28. Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma.
Wu SG; Gow CH; Yu CJ; Chang YL; Yang CH; Hsu YC; Shih JY; Lee YC; Yang PC
Eur Respir J; 2008 Oct; 32(4):924-30. PubMed ID: 18508816
[TBL] [Abstract][Full Text] [Related]
29. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.
Musani AI; Haas AR; Seijo L; Wilby M; Sterman DH
Respiration; 2004; 71(6):559-66. PubMed ID: 15627865
[TBL] [Abstract][Full Text] [Related]
30. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions.
Marqués M; Pont M; Hidalgo I; Sorolla MA; Parisi E; Salud A; Sorolla A; Porcel JM
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762343
[TBL] [Abstract][Full Text] [Related]
32. Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions.
Budna J; Kaczmarek M; Kolecka-Bednarczyk A; Spychalski Ł; Zawierucha P; Goździk-Spychalska J; Nowicki M; Batura-Gabryel H; Sikora J
J Immunol Res; 2018; 2018():9876014. PubMed ID: 29785404
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic molecular biomarkers for malignant pleural effusions.
Sriram KB; Relan V; Clarke BE; Duhig EE; Yang IA; Bowman RV; Lee YC; Fong KM
Future Oncol; 2011 Jun; 7(6):737-52. PubMed ID: 21675837
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging.
Chen L; Zhang G; Sheng S; Zhou Q; Pan Y; Guan S
Clin Chim Acta; 2016 Jun; 457():81-5. PubMed ID: 27071700
[TBL] [Abstract][Full Text] [Related]
35. Video-assisted thoracoscopic surgery pleurectomy: a suitable alternative for treating malignant pleural effusions.
Diggs LP; Martin SP; Drake JA; Ripley RT
J Thorac Dis; 2021 Apr; 13(4):2177-2183. PubMed ID: 34012568
[TBL] [Abstract][Full Text] [Related]
36. Survival of lung adenocarcinoma patients with malignant pleural effusion.
Wu SG; Yu CJ; Tsai MF; Liao WY; Yang CH; Jan IS; Yang PC; Shih JY
Eur Respir J; 2013 Jun; 41(6):1409-18. PubMed ID: 23018906
[TBL] [Abstract][Full Text] [Related]
37. Review: Cell Dynamics in Malignant Pleural Effusions.
Giarnieri E; Bellipanni G; Macaluso M; Mancini R; Holstein AC; Milanese C; Giovagnoli MR; Giordano A; Russo G
J Cell Physiol; 2015 Feb; 230(2):272-7. PubMed ID: 25205557
[TBL] [Abstract][Full Text] [Related]
38. Pleural Effusion IL-33/sST2 Levels and Effects of Low and High IL-33/sST2 Levels on Human Mesothelial Cell Adhesion and Migration.
Kotsiou OS; Jagirdar RM; Papazoglou ED; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Inflammation; 2019 Dec; 42(6):2072-2085. PubMed ID: 31429014
[TBL] [Abstract][Full Text] [Related]
39. Metastatic Pleural Effusion: An Unusual Presentation of Urothelial Bladder Carcinoma.
Javed IN; Abdo T; Ahmad N; Jones KR
Cureus; 2019 May; 11(5):e4619. PubMed ID: 31312546
[TBL] [Abstract][Full Text] [Related]
40. CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
Bruschini S; di Martino S; Pisanu ME; Fattore L; De Vitis C; Laquintana V; Buglioni S; Tabbì E; Cerri A; Visca P; Alessandrini G; Facciolo F; Napoli C; Trombetta M; Santoro A; Crescenzi A; Ciliberto G; Mancini R
J Cell Physiol; 2020 Mar; 235(3):1877-1887. PubMed ID: 31397494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
